Resultado de búsqueda
13 de nov. de 2020 · To our knowledge, the ARREST trial is the first randomised interventional trial to assess the effect of early ECMO-facilitated resuscitation compared with standard ACLS treatment for survival of patients with out-of-hospital refractory cardiac arrest.
27 de ago. de 2023 · The ARREST trial is an investigator-led, prospective, parallel, multicentre, open-label, randomised superiority trial in which expedited transfer to a cardiac arrest centre was compared with current standard of care, comprising patient transfer to the geographically closest emergency department following resuscitated OHCA.
3 de jul. de 2021 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet.2020; 3961807-1816. Summary. The ARREST trial was a phase 2, single-centre, open-label, adaptive, safety and efficacy randomised ...
14 de dic. de 2020 · The ARREST trial Yannopoulos D, Bartos J, Raveendran G, Walser E, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.
20 de nov. de 2020 · ARREST. 20 November 2020 George Walker Emergency Medicine, Intensive Care Medicine 2 comments. Tweet. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. D Yannopoulos et al.
25 de ene. de 2023 · The ARREST trial was terminated early because of superiority of the intervention: survival to discharge occurred in 6 of 14 patients (43%) in the group that received extracorporeal CPR as...
29 de ago. de 2021 · A recent randomized trial involving patients with cardiac arrest without ST-segment elevation that compared immediate angiography with delayed angiography showed no significant between-group...